Induced Antileukemic Activity after Blast Modulation is Independent from Immune Checkpoint Marker Expression on Patients’ Blasts or T Cells. acbr. 2025;9(6):521-541. Accessed September 17, 2026. https://fortunejournals.org/ojs/index.php/acbr/article/view/15154